To evaluate in vitro the capture efficiency of a distal protection filter (DPF) used during carotid artery stenting and examine the longitudinal vascular impedance in the presence of a DPF.
Methods:
Four approved DPFs (Spider RX, FilterWire EZ, RX Accunet, and FiberNet) were evaluated in a physiologically realistic in vitro setup. A pulsatile programmable piston pump circulated a blood analog at a time-varying flow rate representative of the human common carotid artery. A silicone carotid bifurcation having average human dimensions was used for the carotid flow model. Microspheres ranging from 40 to 900 µm were injected to simulate embolization. The longitudinal vascular impedance was calculated as the ratio of the time-varying pressure gradient across the DPF to the time-varying flow rate in the internal carotid artery.
Results:
RX Accunet had the highest capture efficiency (99.4%) and Spider RX the lowest (78.1%). Spider RX increased the longitudinal vascular impedance the least after deployment (+23%), while FilterWire EZ increased the longitudinal vascular impedance the least after particles were injected (+29%). FiberNet increased longitudinal vascular impedance the most (+84%).
Conclusion:
This investigation, unique for examining the effects of physiologically realistic pulsatile flow on DPF performance, can aid in the development of future generations of novel DPFs.
BatesERBabbJDCaseyDE. ACCF/SCAI/SYMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation task force on clinical expert consensus documents (ACCF/SCAI/SYMB/SIR/ASITN clinical expert consensus document committee on carotid stenting). J Am Coll Cardiol. 2007;49:126–170.
2.
North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453.
3.
HobsonRWHowardVJRoubinGS. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004;40:1106–1111.
4.
KastrupAGroschelKNageleT. Effects of age and symptom status on silent ischemic lesions after carotid stenting with and without the use of distal filter devices. AJNR Am J Neuroradiol. 2008;29:608–612.
5.
WholeyMHAl-MubarekNWholeyMH.Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv. 2003;60:259–266.
6.
MasJLChatellierGBeyssenB.Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke. 2004;35:e18–20.
7.
BarbatoJEDillavouEHorowitzMB. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg. 2008;47:760–765.
8.
VosJAvan den BergJCErnstSM. Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology. 2005;234:493–499.
9.
Müller-HülsbeckSStolzmannPLiessC. Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. Radiology. 2005;235:454–460.
10.
OhkiTRoubinGSVeithFJ. Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: an ex vivo analysis. J Vasc Surg. 1999;30:1034–1044.
11.
FinolEASiewiorekGMScottiCM. Wall apposition assessment and performance comparison of distal protection filters. J Endovasc Ther. 2008;15:177–185.
12.
HendriksJMZindlerJDvan der LugtA. Embolic protection filters for carotid stenting: differences in flow obstruction depending on filter construction. J Endovasc Ther. 2006;13:47–50.
13.
Müller-HülsbeckSGrimmJLiessC. Comparison and modification of two cerebral protection devices used for carotid angioplasty: in vitro experiment. Radiology. 2002;225:289–294.
14.
Müller-HülsbeckSJahnkeTLiessC. In vitro comparison of four cerebral protection filters for preventing human plaque embolization during carotid interventions. J Endovasc Ther. 2002;9:793–802.
15.
Müller-HülsbeckSJahnkeTLiessC. Comparison of various cerebral protection devices used for carotid artery stent placement: an in vitro experiment. J Vasc Interv Radiol. 2003;14:613–620.
16.
Müller-HülsbeckSHüslerEJSchaffnerSR. An in vitro analysis of a carotid artery stent with a protective porous membrane. J Vasc Interv Radiol. 2004;15:1295–1305.
17.
SiewiorekGMWholeyMHFinolEA.In vitro performance assessment of distal protection devices for carotid artery stenting: effect of physiological anatomy on vascular resistance. J Endovasc Ther. 2007;14:712–724.
18.
SiewiorekGMWholeyMHFinolEA.Vascular resistance in the carotid artery: an in vitro investigation of embolic protection filters. J Vasc Interv Radiol. 2008;19:1467–1476.
19.
HoldsworthDWRickeyDWDrangovaM. Computer-controlled positive displacement pump for physiological flow simulation. Med Biol Eng Comput. 1991;29:565–570.
20.
HoldsworthDWNorleyCJFrayneR. Characterization of common carotid artery blood-flow waveforms in normal human subjects. Physiol Meas. 1999;20:219–240.
21.
SmithRFRuttBKFoxAJ. Geometric characterization of stenosed human carotid arteries. Acad Radiol. 1996;3:898–911.
22.
HenryMAmorMHenryI. Carotid stenting with cerebral protection: first clinical experience using the PercuSurge GuardWire system. J Endovasc Surg. 1999;6:321–331.
23.
GrubeESchoferJJWebbJ. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol. 2002;89:941–945.
24.
NicholsWWO'RourkeMF.Mcdonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. Philadelphia: Lea & Febiger; 1990.
25.
GaspardSSiewiorekGMFinolEA.Performance assessment of a cerebral protection device by in vitro testing and computational fluid dynamics. Proceedings of the 2006 Summer Bioengineering Conference, abstract BIO2006-158114; Amelia Island, FL, USA; June21–25, 2006.
26.
GaspardSSiewiorekGMFinolEA.Experimental and computational flow modeling of cerebral protection devices for carotid artery stenting. J Biomech. 2006;39Suppl 1:S308.
27.
PowalowskiTPenskoB.Non-invasive ultrasonic method for the blood flow and pressure measurements to evaluate the hemodynamic properties of the cerebrovascular system. Arch Acoustics. 1985;10:303–314.
28.
RappJHZhuLHollenbeckK. Distal filtration versus flow reversal: an ex vivo assessment of the choices for carotid embolic protection. J Vasc Surg. 2009;49:1181–1188.
29.
HenryMPolydorouAHenryI. New distal embolic protection device the FiberNet 3 dimensional filter: first carotid human study. Catheter Cardiovasc Interv. 2007;69:1026–1035.
